- Risk of heart disease can be reduced by rheumatoid arthritis medicine: Study Hindustan Times
- DMARDs for RA Improve Vascular Inflammation and CV Risk Medscape
- Addition of TNFi, Triple Therapy Improved Vascular Inflammation in Patients with RA Rheumatology Network
- View Full coverage on Google News
Risk of heart disease can be reduced by rheumatoid arthritis medicine: Study – Hindustan Times
ByGoogle News
Dec 9, 2022